T cell mechanisms in the immunopathogenesis of viral hepatitis B and C

被引:22
|
作者
Tsai, SL
Huang, SN
机构
[1] NATL TAIWAN UNIV, COLL MED, TAIPEI 10018, TAIWAN
[2] UNIV TORONTO, SUNNYBROOK HLTH SCI CTR, DEPT PATHOL, N YORK, ON, CANADA
关键词
cytotoxic T lymphocyte; hepatitis B; hepatitis C; MHC-restriction; T cell epitope; T cell response;
D O I
10.1111/j.1440-1746.1997.tb00505.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Considerable evidence suggests that immune mechanisms are involved in the pathogenesis of both hepatitis B and C. Both CD4(+) and CD8(+) T cell responses to viral antigens are important mechanisms that may be responsible for the hepatocyte damage in hepatitis B and C. CD4(+) T cell proliferative responses to hepatitis B core antigen (HBcAg) in terms of stimulation index are correlated with hepatitis activity These responses can be demonstrated in both adult and paediatric patients, and are more vigorous in patients with acute self-limited hepatitis B than in patients with chronic hepatitis B. Patients with hepatitis C also had a significant CD4(+) T cell response to hepatitis C virus (HCV) antigens. These responses are also vigorous in acute hepatitis C with recovery than in those cases that evolve to chronic hepatitis C. In terms of human leucocyte antigen (HLA) class I-restricted, CD8(+) cytotoxic T lymphocyte (CTL) response, antigenic peptides derived from HBcAg, hepatitis B surface antigen (HBsAg), and polymerase have been demonstrated as the targets for CTL recognition in hepatitis B patients. Multiple CTL epitopes within both HBsAg and HBcAg can be detected by sensitizing target cells with synthetic peptides. Similar to hepatitis B virus (HBV) infection, multispecific, HCV-specific CTL responses can coexist with an extensive quasispecies of viral variants. The mechanisms of viral persistence in both hepatitis B and C are not yet clarified.
引用
收藏
页码:S227 / S235
页数:9
相关论文
共 50 条
  • [41] Hepatitis C cell culture system – a valuable tool for understanding viral resistance mechanisms
    Costin-Ioan Popescu
    Ovidiu Vlaicu
    Leontina Bănică
    Simona Paraschiv
    Dan Oțelea
    BMC Infectious Diseases, 14 (Suppl 4)
  • [42] Immune mechanisms of viral clearance and pathogenesis of hepatitis C
    Wedemeyer, H
    IMMUNOLOGICAL DISEASES OF LIVER AND GUT, 2004, 135 : 57 - 71
  • [43] Viral hepatitis B und C [Virushepatitis B und C]
    Reiser M.
    Medizinische Klinik, 2009, 104 (5) : 356 - 362
  • [44] Prevention of viral hepatitis (B and C) reassessed
    Van Herck, Koen
    Vorsters, A.
    Van Damme, P.
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2008, 22 (06) : 1009 - 1029
  • [45] The A, B, C, D and E of viral hepatitis
    Slavkin, HC
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1996, 127 (11): : 1667 - 1670
  • [46] COMBINED VIRAL B-HEPATITIS AND C-HEPATITIS
    LEEVY, CB
    AGIUS, C
    ZWEIL, P
    GARCIA, GS
    HEPATOLOGY, 1990, 12 (02) : 422 - 422
  • [47] Viral infections and the kidney: HIV, hepatitis B, and hepatitis C
    Appel, Gerald
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2007, 74 (05) : 353 - 360
  • [48] Emerging viral hepatitis B and C in Estonia
    Priimägi, J
    Tefanova, V
    Tallo, T
    EMERGING BIOLOGICAL THREATS, 2005, 370 : 20 - 25
  • [49] Viral Hepatitis : Focus on Clinical Manifestations of Hepatitis A, B and C
    Lee, Kwan Sik
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2005, 48 (05): : 428 - 439
  • [50] Immune (T cell) response in viral hepatitis
    Gerlach, JT
    Gruener, N
    Diepolder, H
    Jung, MC
    Pape, GR
    IMMUNOLOGY & LIVER, 2000, 114 : 207 - 215